Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05264025
PHASE1/PHASE2

Fexofenadine in Patients With Active Rheumatoid Arthritis

Sponsor: October 6 University

View on ClinicalTrials.gov

Summary

Rheumatoid arthritis (RA) is an inflammatory autoimmune polyarthritis affecting ∼1% of the world population, resulting in the loss of joint function and progressive structural damage in affected joints. Fexofenadine has been widely used to treat various allergic diseases, like allergic rhinitis, conjunctivitis and chronic idiopathic urticaria. the molecular mechanisms underlying fexofenadine mediated inhibition of TNF-α signalling

Official title: Fexofenadine as Adjunct to Standard Rheumatoid Therapy in Patients With Active Rheumatoid

Key Details

Gender

All

Age Range

18 Years - 60 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2022-06-01

Completion Date

2026-01

Last Updated

2025-07-31

Healthy Volunteers

Yes

Interventions

DRUG

Fexofenadine

tablet

DRUG

Placebo

tablet

Locations (2)

Beni-Suef Hospital

Banī Suwayf, Egypt

Faculty of Medicine - Beni Suef Hospital

Banī Suwayf, Egypt